JPRN-UMIN000007113招募中未知
Evaluation of efficacy and safety of combinationtherapy with trastuzumab and eribulin for HER2-positive inoperableness or metastatic breast cancer - Combination therapy of trastuzumab and eribulin
Wakayama Medical University Department of Thoracic and Cardiovascular Surgery0 个研究点目标入组 35 人开始时间: 2013年12月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •(1)With serious drug allergy (2) Systemic infection (3) Control of pleural effusion, ascites and pericardial fluid (4)Clinical symptoms with brain metastasis (5) Severe complications 1) Control of bad heart disease 2) Myocardial infarction within 6 months 3) Cirrhosis 4) Between interstitial Pneumonitis and pulmonary fibrosis 5) Bleeding tendency (6) Active cancer (7) Pregnancy, breast feeding or wish of future bearing (8) Long-term corticosteroid therapy (9) Wide range of radiation therapy (10)Refusal of blood transfusion (11) Patients considered inappropriate by the study investigator
研究者
相似试验
已完成
4 期
Evaluation on efficacy and safety of a combination therapy of rituximab with bendamustin in the patients with relapsed or resistnat low grade B-cell non-Hodgkin lymphomapatients with relapsed or resistant low grade B-cell non-Hodgkin lymphomaJPRN-UMIN000008638Hiroshima University26
招募中
2 期
Evaluation of the safety and efficacy of combination of neostigmine and ketorolac added to reduced local anesthetic mixture dose through medial canthus injection in vitrectomy surgeryAnaesthesiaPACTR202204650206424Research institute of Ophthalmology50
招募中
不适用
The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancerJPRN-UMIN000014099Gunma University20
已完成
不适用
The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancerocally advanced esophageal cancerJPRN-UMIN000017350Gunma University6
招募中
2 期
Clinical study on VAMHA and MYRHA Tablets in Polycystic ovary syndromeCTRI/2022/12/048147Gynoveda Femtech Pvt. Ltd